Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug
Abstract
Nitroglycerine (NTG) given prior to an ischaemic insult exerts cardioprotective effects. However, whether administration of an acute low dose of NTG in a clinically relevant manner following an ischaemic episode limits infarct size, has not yet been explored.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 27, 2018
- Source ID
- 10.1093/cvr/cvy222
Entities
People
- Andreas Daiber
- Andreas Papapetropoulos
- Athanasia Chatzianastasiou
- Derek J Hausenloy
- Efstathios K Iliodromitis
- Ingrid Fleming
- Ioanna Andreadou
- Kyriakos E Kypreos
- Peter Brouckaert
- Sebastian Steven
- Sofia-iris Bibli
- Voahanginirina Randriamboavonjy
Organizations
- Bodossaki Foundation
- British Heart Foundation
- Ernst Schering Foundation
- European Cooperation in Science and Technology
- European Society of Cardiology
- Flanders Institute for Biotechnology
- German Research Foundation
- Ghent University
- Goethe University Frankfurt
- National Institute for Health and Care Research
- National and Kapodistrian University of Athens
- Naval Medical Research Center
- University College London
- University Medical Center
- Yong Loo Lin School of Medicine